2026 Q2 Portfolio Activity
In 2026 Q2, Velan Capital Investment Management LP maintained a portfolio of 56 distinct positions. The most significant new addition was C4 THERAPEUTICS INC, now representing 1.62% of the total fund value. They heavily accumulated shares in IMMIX BIOPHARMA INC, increasing the position by 46.6%. The fund also reduced its exposure to TENAX THERAPEUTICS INC by 88.2%.
Position History
hover any row below to update
Loading…
Total Positions
56
Quarter
2026 Q2
Top Holding
PRAX (18.1%)
Top 10 Concentration
74.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 56
Velan Capital Investment Management LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 18.10% | 20.34% |
#1
Prev: #1
|
6.5 |
—
|
-12,000 | -11.9% |
P
S
|
88,781 | $29,722,991 |
$22.83
+1151.1%
|
2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 10.76% | 6.28% |
#2
3
Prev: #5
|
6.5 |
—
|
no change | no change |
P
S
|
492,893 | $17,665,285 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
STRO
SUTRO BIOPHARMA...
|
Healthcare | 10.36% | 7.99% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
512,160 | $17,003,712 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 6.81% | 4.22% |
#4
5
Prev: #9
|
5.7 |
—
|
345,000 | 46.6% |
P
S
|
1,085,000 | $11,186,350 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARA
PROTARA THERAPE...
|
Healthcare | 6.62% | 9.25% |
#5
3
Prev: #2
|
3.6 |
—
|
10,000 | 0.4% |
P
S
|
2,844,652 | $10,866,571 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 5.33% | 5.37% |
#6
1
Prev: #7
|
2.6 |
—
|
-11,370 | -14.8% |
P
S
|
65,630 | $8,745,854 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 4.87% | 5.84% |
#7
1
Prev: #6
|
2.4 |
—
|
-33,348 | -5.7% |
P
S
|
549,985 | $8,002,282 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVR
ANTERIS TECHNOL...
|
Healthcare | 4.20% | 2.43% |
#8
4
Prev: #12
|
2.7 |
—
|
no change | no change |
P
S
|
700,000 | $6,895,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EDSA
EDESA BIOTECH I...
|
Healthcare | 4.10% | 2.71% |
#9
2
Prev: #11
|
2.6 |
—
|
no change | no change |
P
S
|
827,500 | $6,727,575 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 3.65% | 6.43% |
#10
6
Prev: #4
|
2.0 |
—
|
5,000 | 1.1% |
P
S
|
451,255 | $5,997,179 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVTX
AVALO THERAPEUT...
|
Healthcare | 3.65% | 1.73% |
#11
4
Prev: #15
|
4.5 |
—
|
139,330 | 75.3% |
P
S
|
324,452 | $5,995,873 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XNCR
XENCOR INC
|
Healthcare | 2.50% | 1.89% |
#12
2
Prev: #14
|
1.5 |
—
|
5,000 | 2.0% |
P
S
|
255,000 | $4,105,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 2.38% | 1.43% |
#13
7
Prev: #20
|
2.0 |
—
|
no change | no change |
P
S
|
750,000 | $3,900,000 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HRTX
HERON THERAPEUT...
|
Healthcare | 2.28% | 4.39% |
#14
6
Prev: #8
|
1.9 |
—
|
no change | no change |
P
S
|
8,753,290 | $3,735,904 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRCA
VERRICA PHARMAC...
|
Healthcare | 1.76% | 1.56% |
#15
3
Prev: #18
|
1.7 |
—
|
no change | no change |
P
S
|
471,559 | $2,885,941 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 1.62% | — |
#16
Prev: #—
|
4.1 |
—
|
570,000 | — |
NEW
|
570,000 | $2,661,900 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EPRX
EUPRAXIA PHARMA...
|
Healthcare | 1.42% | 1.60% |
#17
1
Prev: #16
|
1.6 |
—
|
no change | no change |
P
S
|
352,000 | $2,326,720 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ADMA
ADMA BIOLOGICS ...
|
Healthcare | 1.27% | — |
#18
Prev: #—
|
4.0 |
—
|
250,000 | — |
NEW
|
250,000 | $2,092,500 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RNTX
REIN THERAPEUTI...
|
Healthcare | 1.08% | — |
#19
Prev: #—
|
3.9 |
—
|
1,700,000 | — |
NEW
|
1,700,000 | $1,768,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LYEL
LYELL IMMUNOPHA...
|
Healthcare | 0.90% | 1.28% |
#20
1
Prev: #21
|
0.9 |
—
|
3,000 | 2.9% |
P
S
|
105,000 | $1,475,250 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
NASUS PHARMA LT...
|
|
Unknown | 0.77% | 0.50% |
#21
5
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
359,390 | $1,257,865 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
PROF
PROFOUND MED CO...
|
Healthcare | 0.69% | 1.16% |
#22
Prev: #22
|
0.3 |
—
|
-115,432 | -40.4% |
P
S
|
170,278 | $1,132,349 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JSPR
JASPER THERAPEU...
|
Healthcare | 0.68% | 1.46% |
#23
4
Prev: #19
|
1.3 |
—
|
no change | no change |
P
S
|
2,668,395 | $1,123,394 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TENX
CALL
TENAX THERAPEUT...
|
CALL Option | 0.61% | — |
#24
Prev: #—
|
3.7 |
—
|
68,700 | — |
NEW
|
68,700 | $999,585 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PTGX
PROTAGONIST THE...
|
Healthcare | 0.28% | 0.24% |
#25
4
Prev: #29
|
1.1 |
—
|
no change | no change |
P
S
|
3,700 | $453,546 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.27% | 1.59% |
#26
9
Prev: #17
|
0.1 |
—
|
-420,000 | -77.8% |
P
S
|
120,000 | $450,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.24% | 0.10% |
#27
13
Prev: #40
|
3.1 |
—
|
150,000 | 187.5% |
P
S
|
230,000 | $391,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 0.24% | 0.16% |
#28
5
Prev: #33
|
1.1 |
—
|
no change | no change |
P
S
|
16,000 | $388,160 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 0.21% | 0.22% |
#29
1
Prev: #30
|
0.6 |
—
|
-30,000 | -18.8% |
P
S
|
130,000 | $349,700 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DTIL
PRECISION BIOSC...
|
Healthcare | 0.19% | 0.14% |
#30
6
Prev: #36
|
1.1 |
—
|
no change | no change |
P
S
|
40,000 | $314,400 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLYS
MINERALYS THERA...
|
Healthcare | 0.18% | 0.19% |
#31
Prev: #31
|
1.1 |
—
|
no change | no change |
P
S
|
11,000 | $296,780 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MGNX
MACROGENICS INC
|
Healthcare | 0.17% | 0.05% |
#32
14
Prev: #46
|
3.1 |
—
|
30,000 | 100.0% |
P
S
|
60,000 | $277,200 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 0.15% | 0.15% |
#33
1
Prev: #34
|
1.1 |
—
|
no change | no change |
P
S
|
26,000 | $243,880 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 0.15% | 0.10% |
#34
5
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
25,000 | $242,500 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 0.13% | 0.10% |
#35
6
Prev: #41
|
1.1 |
—
|
no change | no change |
P
S
|
20,000 | $221,400 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 0.13% | 0.15% |
#36
1
Prev: #35
|
1.1 |
—
|
no change | no change |
P
S
|
10,000 | $218,600 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMNM
IMMUNOME INC
|
Healthcare | 0.13% | 0.14% |
#37
Prev: #37
|
1.1 |
—
|
no change | no change |
P
S
|
10,000 | $211,900 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TECX
TECTONIC THERAP...
|
Healthcare | 0.13% | — |
#38
Prev: #—
|
3.6 |
—
|
6,000 | — |
NEW
|
6,000 | $206,250 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RCKT
ROCKET PHARMACE...
|
Healthcare | 0.12% | 0.66% |
#39
15
Prev: #24
|
0.0 |
—
|
-234,643 | -79.6% |
P
S
|
60,000 | $205,200 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.12% | 0.05% |
#40
7
Prev: #47
|
2.5 |
—
|
5,000 | 33.3% |
P
S
|
20,000 | $195,400 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANTX
AN2 THERAPEUTIC...
|
Healthcare | 0.12% | — |
#41
Prev: #—
|
3.5 |
—
|
40,000 | — |
NEW
|
40,000 | $193,600 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 0.11% | 1.12% |
#42
19
Prev: #23
|
0.0 |
—
|
-81,123 | -89.0% |
P
S
|
10,000 | $183,700 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
SCYNEXIS INC
|
|
Unknown | 0.10% | — |
#43
Prev: #—
|
3.5 |
—
|
40,000 | — |
NEW
|
40,000 | $162,800 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
QNRX
QUOIN PHARMACEU...
|
Healthcare | 0.10% | 0.35% |
#44
17
Prev: #27
|
0.0 |
—
|
-52,477 | -61.8% |
P
S
|
32,372 | $156,680 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
XILIO THERAPEUT...
|
|
Unknown | 0.08% | 0.08% |
#45
2
Prev: #43
|
1.0 |
—
|
no change | no change |
P
S
|
14,285 | $136,850 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
NSPR
INSPIREMD INC
|
Healthcare | 0.06% | 2.14% |
#46
33
Prev: #13
|
0.0 |
—
|
-1,951,514 | -92.9% |
P
S
|
148,138 | $103,711 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KLRS
KALARIS THERAPE...
|
Healthcare | 0.06% | 0.07% |
#47
3
Prev: #44
|
2.5 |
—
|
7,000 | 38.9% |
P
S
|
25,000 | $101,750 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 0.06% | 0.09% |
#48
6
Prev: #42
|
1.0 |
—
|
no change | no change |
P
S
|
33,000 | $100,650 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRQR
PROQR THRAPEUTI...
|
Healthcare | 0.05% | 0.05% |
#49
1
Prev: #48
|
1.0 |
—
|
no change | no change |
P
S
|
45,000 | $83,700 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.02% | 0.16% |
#50
18
Prev: #32
|
0.0 |
—
|
-40,300 | -40.3% |
P
S
|
59,700 | $33,068 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 56 holdings